Dysfunction of natural killer activity in a family with chronic fatigue syndrome

Clinical Immunology and Immunopathology

Volumn 88, Issue 1, 1998, Pages 96-104

  Levine, Paul H ^a   Whiteside, Theresa L ^b   Friberg, Diana ^b   Bryant, John ^b   Colclough, Ginga ^c   Herberman, Ronald B ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c RTI INTERNATIONAL   (United States)

Author keywords

Chronic fatigue syndrome; Familial CFS; Natural killer cells; NK activity

Indexed keywords

ARTHRALGIA; ARTICLE; CANCER RISK; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILY; HUMAN; HUMAN CELL; MYALGIA; NATURAL KILLER CELL; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0031876945     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1998.4554     Document Type: Article

References (32)

1. Holmes G. P., Kaplan J. E., Gantz N. M., Komaroff A. L., Schonberger L. B., Straus S. E. Chronic fatigue syndrome: A working case definition. Ann. Intern. Med. 108:1988;387-439.
2. Fukuda K., Straus S., Hickie I. Chronic fatigue syndrome: A comprehensive approach to its definition and study. Ann. Intern. Med. 121:1994;953-959.
3. Poskanzer D. C., Henderson D. A., Kunkle E. C., Kalter S. S., Clemeni W. B. Epidemic neuromyasthenia: An outbreak in Punta Gorda, Florida. N. Engl. J. Med. 257:1957;356-364.
4. Buchwald D., Cheney P. R., Peterson D. L., Henry B., Wormsley S. E., Geiger A. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpes virus type 6 infection. Ann. Intern. Med. 116:1992;103-113.
5. Levine P. H., Jacobson S., Pocinki A. Q., Cheney F., Peterson D., Connelly R. R. Clinical, epidemiologic, and virologic studies in four clusters of the chronic fatigue syndrome. Arch. Intern. Med. 152:1992;1611-1616.
6. Levine P. H. Epidemiologic aspects of chronic fatigue syndrome/myalgic encephalomyelitis. The Clinical and Scientific Basis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. 1992;Ottawa Univ. Press, Ottawa. p. 196-205.
7. Aoki R., Usuda T., Miyakoshi N., Tamua K., Herberman R. Low NK syndrome (LNKS): Clinical and immunologic teachers. Nat. Immun. Cell Growth Regul. 6:1987;116-128.
8. Aoki T., Miyakoshi H., Usuda Y., Herberman R. B. Low NK syndrome and its relationship to chronic fatigue syndrome. Clin. Immunol. Immunopathol. 69:1993;253-265.
9. Caligiuri M., Murray C., Buchwald D. Phenotypicand functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J. Immunol. 139:1987;3306-3313.
10. Ojo-Amaize E. A., Conley E. J., Peter J. B. Decreased NK cell activity is associated with severity of chronic fatigue immune dysfunction syndrome. Clin. Infect. Dis. 18:1994;S157-S159.
11. Barker E., Fujimura S. F., Fadem M. B., Landay A. L., Levy J. A. Immunologic abnormalities associated with chronic fatigue syndrome. Clin. Infect. Dis. 18:1994;S136-S141.
12. Whiteside T. L., Bryant J., Day R., Herberman R. B. Natural killer cytotoxicity in the diagnosis of immune dysfunction: Criteria for a reproducible assay. J. Clin. Lab. Anal. 4:1990;102-114.
13. Pross H. F., Baines M. G., Rubin P., Schragge P., Patterson M. D. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. J. Clin. Immunol. 1:1981;51-63.
14. Jones J. F., Straus S. E. Chronic Epstein-Barr virus infection. Annu. Rev. Med. 38:1987;195-209.
15. Olsen C. B., Kansan M. N., Gersuk G. M., Kelley L. M., Jones J. F. Correlation between allergy and persistent Epstein-Barr virus infections in chronic-active Epstein-Barr virus-infected patients. J. Allergy Clin. Immunol. 78:1986;308-314.
16. Straus S. E., Dale J. K., Wright R., Metcalfe D. D. Allergy and the chronic fatigue syndrome. J. Allergy Clin. Immunol. 81:1988;791-795.
17. King M-C. Genetic epidemiology of human cancer. Burchenal J. H., Oettgen H. F. Cancer: Achievements, Challenges and Prospects for the 1980s. 1981;397-405 Grune & Stratton, New York.
18. Anderson D. E. Clinical characteristics for the genetic variety of cutaneous melanoma in man. Cancer. 28:1971;721-725.
19. Emery A. E. H., Rimoin D. L. Principles and Practice of Medical Genetics. 1990;Churchill Livingstone, New York. p. 375-376.
20. Klimas N. G., Salvato F. R., Morgan R., Fletcher M. A. Immunologic abnormalities in chronic fatigue syndrome. J. Clin. Microbiol. 28:1990;1403-1410.
21. Eby N. L., Grufferman S., Huang M., Whiteside T., Sumaya C., Saxinger W. C., Herberman R. B. Natural killer cell activity in the chronic fatigue-immune dysfunction syndrome. Ades E. W., Lopez C. Natural Killer Cells and Host Defense. 1989;141-145 Karger, Basel.
22. Hersey P., Edwards A., Honeyman M., McCarthy W. H. Low natural killer-cell activity in familial melanoma patients and their relatives. Br. J. Cancer. 40:1979;113-122.
23. Strayer D. R., Carter W. A., Mayberry S. D., Pequignot E., Brodsky I. Low natural cytotoxicity of peripheral blood mononuclear cells in individuals with high familial incidence of cancer. Cancer Res. 44:1984;370-374.
24. Strayer D. R., Carter W. A., Brodsky I. Familial occurrence of breast cancer is associated with reduced natural killer cytotoxicity. Breast Cancer Res. Treat. 7:1986;187-192.
25. Whiteside T. L., Herberman R. B. Role of natural killer cells in immune surveillance of cancer. Curr. Opin. Immunol. 7:1995;704-710.
26. Levy S. M., Herberman R. B., Simons A., Whiteside T. L., Lee J., McDonald R., Beadle M. Persistently low natural killer cell activity in normal adults: Immunological, hormonal, and mood correlates. Nat. Immun. Cell Growth Regul. 8:1989;173-186.
27. Levy S. M., Herberman R. B., Lee J., Whiteside T. L., Beadle M., Heiden L., Simons A. Persistently low natural killer cell activity, age, and environmental stress as predictors of infectious morbidity. Nat. Immun. Cell Growth Regul. 10:1991;289-307.
28. Schedlowski M., Jacobs R., Stratmann G., Richter S. Changes in natural killer cells during acute psychological stress. J. Clin. Immunol. 13:1993;119-126.
29. O'Leary A. Stress, emotion and human immune function. Psychol. Bull. 108:1990;363-382.
30. Siber W. J., Rodin J., Larson L., Ortega S., Cummings N., Levy S., Whiteside T. L., Herberman R. B. Modulation of human natural killer cell activity by exposure to uncontrollable stress. Brain Behav. Immun. 6:1992;141-156.
31. Whiteside T. L., Rinaldo C. R., Herberman R. B. Cytolytic cell functions. Rose N. R., deMacario E. C., Fahey J. L., Friedman H., Penn G. M. Manual of Clinical Laboratory Immunology. 1992;220-230 Am. Soc. Microbiol. Washington.
32. Tirelli U., Marotta G., Imorota S., Pinto S. Immunologic abnormalities in patients with chronic fatigue syndrome. Scand. J. Immunol. 40:1994;601-608.